About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

IV Dexketoprofen vs Placebo in Migranie Attack | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 4NCT02159547

IV Dexketoprofen vs Placebo in Migranie Attack

H0 hypothesis: IV dexketoprofen is equivalent to placebo in ceasing migraine attack in emergency department. H1 hypothesis: IV dexketoprofen is not equivalent (superior) to placebo in ceasing migrain...

Lead sponsor: Akdeniz University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Akdeniz University

Migraine attack is one of the most leading causes presentations to emergency department. Patients with migraine attack seek urgent care to cease their pain. There are so many interventions defined in the medical literature that can be used in migraine attacks. However, as a IV drug, dexketoprofen; little known whether IV dexketoprofen is superior to placebo or not. In the present study we aimed to determine the effects of IV dexketoprofen in migraine attack in emergency department.

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•patients presented with headache who diagnosed as migraine attack according to the international headache society

Exclusion Criteria

•denied to give inform concent, illiterate patients, chronic renal failure, taking NSAIDs during the last six hours, pregnancy

Related studies

Yogabased Movements for Primary Headaches (Migraine and/or Cluster Headache) - YOURHEAD

NCT07348783 · Cluster Headache - Episodic and Chronic, Migraine Headache, and more

Chiropractic Care for Episodic Migraine

NCT06229834 · Episodic Migraine

Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine

NCT06603558 · Chronic Migraine, Episodic Migraine, and more

BE WELL With Migraine: Brain Education and WELLness With Migraine

NCT05987592 · Migraine

i-NEED: NEw migrainE Drugs Database

NCT07103694 · Episodic Migraine, Chronic Migraine, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 23, 2015Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment224

Start dateMay 2014

Last updatedJul 23, 2015

Condition

Locations shown

Antalya Training and Govermental Hospital

Antalya

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 23, 2015Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions